Granite Investment Partners’s Tandem Diabetes Care TNDM Stock Holding History

Granite Investment Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-319,524	Closed	-$14.4M	–	280
2022 Q4	$14.4M	Sell	319,524 -26,700	-8%	-$1.21M	0.6%	62
2022 Q3	$16.6M	Buy	+346,224	New	+$19M	0.72%	50
2017 Q2	–	Sell	-44,892	Closed	-$539K	–	313
2017 Q1	$539K	Buy	44,892 +10,336	+30%	+$226K	0.04%	273
2016 Q4	$743K	Buy	34,556 +19,148	+124%	+$737K	0.05%	258
2016 Q3	$1.18M	Buy	+15,408	New	+$1.12M	0.09%	220
2015 Q1	–	Sell	-6,654	Closed	-$845K	–	307
2014 Q4	$845K	Sell	6,654 -6,073	-48%	-$842K	0.1%	239
2014 Q3	$1.71M	Buy	12,727 +4,668	+58%	+$654K	0.23%	125
2014 Q2	$1.31M	Buy	+8,059	New	+$1.37M	0.19%	121

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Granite Investment Partners's TNDM Position: Q1 2023 in Review

Granite Investment Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 319,524 shares — an estimated $14.4M sold.

Granite Investment Partners first reported a position in TNDM in Q2 2014 and held it in 8 quarters. The position peaked at $16.6M in Q3 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

Granite Investment Partners reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
Granite Investment Partners sold 319,524 Tandem Diabetes Care shares in Q1 2023, an estimated $14.4M.
Granite Investment Partners first reported a position in Tandem Diabetes Care in Q2 2014 and held it in 8 quarters.
Granite Investment Partners's Tandem Diabetes Care position peaked at $16.6M in Q3 2022.
273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Granite Investment Partners's 13F filing for Q1 2023, filed 3 May 2023.